Sanofi Oncology announces new FDA approval

04 Aug 2012 8:41 PM | Lori Aubrey (Administrator)

NNECOS FDA Approval Page

Sanofi Oncology Anounces FDA Approval of Zaltrap for metastatic colorectal cancer

August 3, 2012: The U.S. Food and Drug Administration approved Zaltrap (ziv-aflibercept) for use in combination with a FOLFIRI (folinic acid, fluorouracil and irinotecan) chemotherapy regimen to treat adults with colorectal cancer.

Read the FDA release.


Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948

This website brought to you by:

Powered by Wild Apricot Membership Software